IRIS
PEA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.806
EU - Europa 3.783
AS - Asia 2.146
SA - Sud America 333
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 2
Totale 21.125
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.737
UA - Ucraina 1.124
SG - Singapore 916
CN - Cina 674
DE - Germania 568
IT - Italia 555
SE - Svezia 484
RU - Federazione Russa 334
BR - Brasile 305
TR - Turchia 280
IE - Irlanda 214
FI - Finlandia 190
GB - Regno Unito 114
VN - Vietnam 75
CA - Canada 54
IN - India 50
FR - Francia 48
KR - Corea 42
BE - Belgio 38
HK - Hong Kong 29
EU - Europa 21
CZ - Repubblica Ceca 20
NL - Olanda 19
EG - Egitto 14
ES - Italia 12
IR - Iran 12
ID - Indonesia 10
RO - Romania 10
JP - Giappone 9
BD - Bangladesh 8
CH - Svizzera 8
MX - Messico 8
IQ - Iraq 7
PL - Polonia 7
AR - Argentina 6
AT - Austria 6
CO - Colombia 6
IL - Israele 5
RS - Serbia 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
MA - Marocco 4
PE - Perù 4
PT - Portogallo 4
TG - Togo 4
TH - Thailandia 4
UZ - Uzbekistan 4
EC - Ecuador 3
LT - Lituania 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CM - Camerun 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
PA - Panama 2
PK - Pakistan 2
SD - Sudan 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
DK - Danimarca 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
Totale 21.125
Salva come PNG Salva come JPEG
Città #
Fairfield 2.203
Woodbridge 1.561
Chandler 1.139
Houston 1.086
Ashburn 1.056
Ann Arbor 962
Wilmington 839
Seattle 828
Cambridge 715
Jacksonville 635
Singapore 490
Dearborn 427
Boardman 349
Beijing 307
Izmir 268
Princeton 237
Dublin 214
Udine 194
Des Moines 173
San Diego 124
Dong Ket 71
Falls Church 58
Redmond 57
New York 47
Norwalk 42
Ogden 40
Brussels 37
Los Angeles 37
Seoul 35
Nanjing 34
Grafing 33
Munich 33
Hefei 28
Ottawa 27
Shanghai 26
São Paulo 26
Helsinki 23
Grugliasco 22
Hong Kong 22
Moscow 22
Kunming 20
Guangzhou 19
Jinan 17
Milan 17
Brno 16
Dallas 16
San Mateo 15
Trieste 15
Bologna 13
Düsseldorf 13
Nuremberg 13
Brasília 12
London 12
Montreal 12
Piemonte 12
West Jordan 12
Wuhan 12
Nanchang 11
Redwood City 11
San Francisco 11
Santa Clara 11
Amsterdam 10
Brooklyn 10
Fuzhou 10
Naples 10
Belo Horizonte 9
Changsha 9
Frankfurt am Main 9
Phoenix 9
Rome 9
Simi Valley 9
Tokyo 9
Venezia 9
Augusta 8
Lauterbourg 8
Monmouth Junction 7
Rio de Janeiro 7
Turin 7
Verona 7
Warsaw 7
Washington 7
Bogor 6
Chicago 6
Curitiba 6
Hyderabad 6
Portsmouth 6
San Jose 6
Tappahannock 6
Toronto 6
Zurich 6
Andover 5
Auburn Hills 5
Boston 5
Brescia 5
Chengdu 5
Hebei 5
Leawood 5
Paris 5
Shenyang 5
Shenzhen 5
Totale 15.091
Salva come PNG Salva come JPEG
Nome #
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? 353
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients? 351
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 222
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 199
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia 178
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 173
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 171
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 161
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies 157
Polypharmacy in an Italian Regional Health system: a survey on drugs use in different healthcare settings 154
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 153
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. 153
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 152
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations. 144
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens 142
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 141
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 140
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 139
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 139
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 139
Population pharmacokinetics and pharmacodynamics of levofloxacin in acutely hospitalized older patients with various degrees of renal function 139
Linezolid underexposure in a patient co-treated with venlafaxine 133
Ceftolozane/tazobactam: place in therapy 131
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 130
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 130
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 129
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 129
Antibiotic therapy in hematological neutropenic patients: what is the news? 128
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. 128
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 126
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 125
- FLUCONAZOLE MONITORING IN LIVER TRANSPLANT RECIPIENTS 124
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 124
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 124
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 123
Pharmacokinetics and drug metabolism of antibiotics in the elderly 123
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 122
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 121
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 121
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp 121
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 121
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 120
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 120
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. 120
Monitoring polypharmacy in healthcare systems through a multi-setting survey: Should we put more attention on long term care facilities? 120
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 118
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 117
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 117
Antimicrobial treatment of bacterial infections in frail elderly patients: The difficult balance between efficacy, safety and tolerability 116
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 116
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 115
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations 115
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 114
Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient 114
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 113
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 113
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 113
Effect of fluctuations of blood cyclosporine concentrations on renal function. 112
Plasma pharmacokinetics of antimicrobial agents in critically Ill patients 112
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 111
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. 111
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections 111
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 110
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report 109
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 109
Procalcitonin-guided antibiotic therapy: An expert consensus 109
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 108
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 108
The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents 107
Practical concept of pharmacokinetics/pharmacodynamics in the management of skin and soft tissue infections 107
Drugs and blood cells 107
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy 107
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats 107
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? 106
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 106
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 106
Daptomycin in solid organ transplantation: Consideration of dosage adjustments in renal impairment 106
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 106
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 106
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 105
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 105
Gentamicin once-daily in enterococcal endocarditis 105
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 104
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review 104
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients 103
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 103
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 103
Blood concentrations and clinical effect of cyclosporin in psoriasis 102
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 101
Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety 101
Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients 101
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 101
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 100
Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance 100
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies 99
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections 99
Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant staphylococcus aureus ventilator-associated pneumonia? 99
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 99
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 99
The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? 97
Totale 12.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020480 0 0 0 0 0 0 0 0 0 0 125 355
2020/20213.375 220 431 130 383 229 345 166 362 392 140 322 255
2021/20222.225 116 198 145 170 88 118 153 104 33 372 402 326
2022/20232.555 274 152 38 332 313 741 0 174 369 27 67 68
2023/2024668 126 53 20 10 114 79 20 57 71 40 28 50
2024/20252.726 111 318 216 126 137 198 189 253 433 281 464 0
Totale 21.812